Advanced Micro Devices R&D increased by 12.9% to $2.14B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 30.7%, from $1.64B to $2.14B. Over 3 years (FY 2021 to FY 2024), R&D shows an upward trend with a 31.4% CAGR.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityStable
First reportedQ1 2007
Last reportedQ3 2025

How to read this metric

High spending signals a focus on long-term innovation, though it reduces current-period net income.

Detailed definition

Expenses related to the innovation, design, and improvement of products and services. In the technology sector, this rep...

Peer comparison

Big Tech firms often reinvest a significant percentage of revenue into R&D to maintain market leadership.

Metric ID: is_research_and_development

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$659.00M$765.00M$811.00M$1.06B$1.30B$1.28B$1.37B$1.41B$1.44B$1.51B$1.51B$1.53B$1.58B$1.64B$1.71B$1.73B$1.89B$2.14B
QoQ Change+16.1%+6.0%+30.7%+22.6%-1.6%+6.8%+3.3%+2.3%+4.4%+0.3%+0.9%+3.8%+3.3%+4.6%+0.9%+9.6%+12.9%
YoY Change+97.3%+67.2%+68.4%+33.1%+11.0%+17.8%+10.6%+8.1%+9.7%+8.6%+13.3%+13.3%+19.6%+30.7%
Range$659.00M$2.14B
CAGR+31.9%
Avg YoY Growth+29.2%
Median YoY Growth+15.6%
Current Streak12 quarters growth

Frequently Asked Questions

What is Advanced Micro Devices's r&d?
Advanced Micro Devices (AMD) reported r&d of $2.14B in Q3 2025.
How has Advanced Micro Devices's r&d changed year-over-year?
Advanced Micro Devices's r&d increased by 30.7% year-over-year, from $1.64B to $2.14B.
What is the long-term trend for Advanced Micro Devices's r&d?
Over 3 years (2021 to 2024), Advanced Micro Devices's r&d has grown at a 31.4% compound annual growth rate (CAGR), from $2.85B to $6.46B.
What does r&d mean?
Money spent on developing new products and improving existing ones.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.